Equities

Glenmark Pharmaceuticals Ltd

GLENMARK:NSI

Glenmark Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,649.80
  • Today's Change7.40 / 0.45%
  • Shares traded995.15k
  • 1 Year change+93.21%
  • Beta1.1527
Data delayed at least 15 minutes, as of Sep 19 2024 11:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments16,58311,59214,105
Total Receivables, Net29,99044,88439,359
Total Inventory27,20925,06526,795
Prepaid expenses2672,2752,199
Other current assets, total233420366
Total current assets74,28184,23682,823
Property, plant & equipment, net35,37541,95146,117
Goodwill, net674736600
Intangibles, net12,67223,42722,254
Long term investments7,897446496
Note receivable - long term1,4801,5181,282
Other long term assets637290332
Total assets143,586193,717170,833
LIABILITIES
Accounts payable26,07720,42123,171
Accrued expenses10,90612,8355,829
Notes payable/short-term debt8,3343,5003,700
Current portion long-term debt/capital leases2,4592,2868,203
Other current liabilities, total10,4106,4205,992
Total current liabilities58,18645,46246,894
Total long term debt1,51740,29327,717
Total debt12,30946,07939,620
Deferred income tax2.805.14315
Minority interest(3.8)3,6533,515
Other liabilities, total5,4059,5641,525
Total liabilities65,10798,97879,966
SHAREHOLDERS EQUITY
Common stock282282281
Additional paid-in capital16,86616,85416,854
Retained earnings (accumulated deficit)80,61096,40393,929
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(19278)(18799)(20198)
Total equity78,47994,73990,866
Total liabilities & shareholders' equity143,586193,717170,833
Total common shares outstanding282282282
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.